I believed under 4.5c would consider to buy while this CR was announced. I reckon HK institutions are active. It’s good for holders, should see a rebound, at least 6.7c gap, imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025